Tag: New York Valves 2024
Cardiac-MRI data from DurAVR FIH study shared at New York Valves
Cardiac magnetic resonance imaging (MRI) data from the first-in-human study of the DurAVR transc...
Six-month TANDEM I results “promising” for Duo tricuspid coaptation system
Six-month results from the TANDEM I first-in-human clinical trial, investigating the CroíValve D...
Biopolymer surgical mitral valve sees favourable results at 30 days
Thirty-day results from the Indian clinical study of the Foldax Tria surgical mitral valve in pa...
First-in-human results with Mirus Siegel TAVI valve presented at New York Valves 2024
Initial experience with the Siegel (Mirus) 8Fr transcatheter aortic valve implantation (TAVI) de...
Investigators find small reduction in disabling stroke from embolic protection device use
Analysis of data from the TVT registry, looking at the impact of cerebral embolic protection dev...
New York Valves hears five-year data from PARTNER trials focused on small annulus patients
Results of an analysis of data from the PARTNER trials examining outcomes of transcatheter aorti...
